scispace - formally typeset
H

Harlan M. Krumholz

Researcher at Yale University

Publications -  1966
Citations -  177853

Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.

Papers
More filters
Journal ArticleDOI

Standards for Statistical Models Used for Public Reporting of Health Outcomes An American Heart Association Scientific Statement From the Quality of Care and Outcomes Research Interdisciplinary Writing Group

TL;DR: The authors identified seven preferred attributes of statistical models used for publicly reported outcomes, including clear and explicit definition of an appropriate patient sample, clinical coherence of model variables, sufficiently high-quality and timely data, designation of appropriate reference time before which covariates are derived and after which outcomes are measured, use of appropriate outcome and a standardized period of outcome assessment, application of an analytical approach that takes into account the multilevel organization of data, and disclosure of the methods used to compare outcomes.
Journal ArticleDOI

Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia

TL;DR: Although there was a significant negative linear relationship between RSMRs and RSRRs for heart failure, the shared variance between them was only 2.9% and the results were similar for subgroups defined by hospital characteristics.
Journal ArticleDOI

Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012

TL;DR: The quality of clinical trial evidence used by the FDA as the basis for recent approvals of novel therapeutic agents varied widely across indications, having important implications for patients and physicians as they make decisions about the use of newly approved therapeutic agents.
Journal ArticleDOI

Consequences of inadequate sign-out for patient care.

TL;DR: Omission of key information during sign-out can have important adverse consequences for patients and health care providers.